▶ 調査レポート

ラニチジン(ザンタック)の世界市場 2020年

• 英文タイトル:Global Ranitidine (Zantac) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ラニチジン(ザンタック)の世界市場 2020年 / Global Ranitidine (Zantac) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201107773資料のイメージです。• レポートコード:GIR201107773
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、ラニチジン(ザンタック)の世界市場を調査対象にし、ラニチジン(ザンタック)の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ラニチジンカプセル、ラニチジン経口錠、ラニチジン注射液、ラニチジン経口シロップ)、用途別分析(病院薬局、小売薬局、オンライン薬局)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Sanofi-Aventis、Strides (and Strides Arcolab international)、Sun Pharma、GlaxoSmithKline、Sandoz Inc. (part of Novartis AG)、Hi-Tech Pharmacal Co.、PAI Holdings, LLC、Dr. Reddy’s Laboratories Inc.、Mylan Pharmaceuticals Inc. (and Mylan Laboratories)、Geri-Care Pharmaceuticals、Hikma Pharmaceuticals (West-ward Pharmaceuticals)、Teva Pharmaceuticals、Apotex Inc. (and Apotex Corporation)、Granules Pharmaceuticals Inc.、Glenmark Pharmaceuticals (and Glenmark Generics)
・メーカー別販売量、売上、市場シェア
・ラニチジン(ザンタック)の地域別市場分析
・ラニチジン(ザンタック)の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・ラニチジン(ザンタック)のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・ラニチジン(ザンタック)のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・ラニチジン(ザンタック)の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・ラニチジン(ザンタック)の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・ラニチジン(ザンタック)の種類別市場規模2015-2020:ラニチジンカプセル、ラニチジン経口錠、ラニチジン注射液、ラニチジン経口シロップ
・ラニチジン(ザンタック)の用途別市場規模2015-2020:病院薬局、小売薬局、オンライン薬局
・ラニチジン(ザンタック)の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The Ranitidine (Zantac) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Ranitidine (Zantac) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Ranitidine (Zantac) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ranitidine (Zantac) market has been segmented into
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup

By Application, Ranitidine (Zantac) has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ranitidine (Zantac) market presented in the report. This section sheds light on the sales growth of different regional and country-level Ranitidine (Zantac) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ranitidine (Zantac) market.

The report offers in-depth assessment of the growth and other aspects of the Ranitidine (Zantac) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Ranitidine (Zantac) Market Share Analysis
Ranitidine (Zantac) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ranitidine (Zantac) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ranitidine (Zantac) sales, revenue and market share for each player covered in this report.

The major players covered in Ranitidine (Zantac) are:
Sanofi-Aventis
Strides (and Strides Arcolab international)
Sun Pharma
GlaxoSmithKline
Sandoz Inc. (part of Novartis AG)
Hi-Tech Pharmacal Co.
PAI Holdings, LLC
Dr. Reddy’s Laboratories Inc.
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Geri-Care Pharmaceuticals
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
Teva Pharmaceuticals
Apotex Inc. (and Apotex Corporation)
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)

Among other players domestic and global, Ranitidine (Zantac) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ranitidine (Zantac) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ranitidine (Zantac), with price, sales, revenue and global market share of Ranitidine (Zantac) in 2018 and 2019.
Chapter 3, the Ranitidine (Zantac) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ranitidine (Zantac) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ranitidine (Zantac) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ranitidine (Zantac) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Ranitidine (Zantac) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ranitidine (Zantac) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Ranitidine Capsule
1.2.3 Ranitidine Oral Tablet
1.2.4 Ranitidine Injectable Solution
1.2.5 Ranitidine Oral Syrup
1.3 Market Analysis by Application
1.3.1 Overview: Global Ranitidine (Zantac) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Overview of Global Ranitidine (Zantac) Market
1.4.1 Global Ranitidine (Zantac) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Sanofi-Aventis Details
2.1.2 Sanofi-Aventis Major Business
2.1.3 Sanofi-Aventis SWOT Analysis
2.1.4 Sanofi-Aventis Product and Services
2.1.5 Sanofi-Aventis Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Strides (and Strides Arcolab international)
2.2.1 Strides (and Strides Arcolab international) Details
2.2.2 Strides (and Strides Arcolab international) Major Business
2.2.3 Strides (and Strides Arcolab international) SWOT Analysis
2.2.4 Strides (and Strides Arcolab international) Product and Services
2.2.5 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharma
2.3.1 Sun Pharma Details
2.3.2 Sun Pharma Major Business
2.3.3 Sun Pharma SWOT Analysis
2.3.4 Sun Pharma Product and Services
2.3.5 Sun Pharma Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sandoz Inc. (part of Novartis AG)
2.5.1 Sandoz Inc. (part of Novartis AG) Details
2.5.2 Sandoz Inc. (part of Novartis AG) Major Business
2.5.3 Sandoz Inc. (part of Novartis AG) SWOT Analysis
2.5.4 Sandoz Inc. (part of Novartis AG) Product and Services
2.5.5 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hi-Tech Pharmacal Co.
2.6.1 Hi-Tech Pharmacal Co. Details
2.6.2 Hi-Tech Pharmacal Co. Major Business
2.6.3 Hi-Tech Pharmacal Co. Product and Services
2.6.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 PAI Holdings, LLC
2.7.1 PAI Holdings, LLC Details
2.7.2 PAI Holdings, LLC Major Business
2.7.3 PAI Holdings, LLC Product and Services
2.7.4 PAI Holdings, LLC Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dr. Reddy’s Laboratories Inc.
2.8.1 Dr. Reddy’s Laboratories Inc. Details
2.8.2 Dr. Reddy’s Laboratories Inc. Major Business
2.8.3 Dr. Reddy’s Laboratories Inc. Product and Services
2.8.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
2.9.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Details
2.9.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Major Business
2.9.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Product and Services
2.9.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Geri-Care Pharmaceuticals
2.10.1 Geri-Care Pharmaceuticals Details
2.10.2 Geri-Care Pharmaceuticals Major Business
2.10.3 Geri-Care Pharmaceuticals Product and Services
2.10.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
2.11.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Details
2.11.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Major Business
2.11.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Product and Services
2.11.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teva Pharmaceuticals
2.12.1 Teva Pharmaceuticals Details
2.12.2 Teva Pharmaceuticals Major Business
2.12.3 Teva Pharmaceuticals Product and Services
2.12.4 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Apotex Inc. (and Apotex Corporation)
2.13.1 Apotex Inc. (and Apotex Corporation) Details
2.13.2 Apotex Inc. (and Apotex Corporation) Major Business
2.13.3 Apotex Inc. (and Apotex Corporation) Product and Services
2.13.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Granules Pharmaceuticals Inc.
2.14.1 Granules Pharmaceuticals Inc. Details
2.14.2 Granules Pharmaceuticals Inc. Major Business
2.14.3 Granules Pharmaceuticals Inc. Product and Services
2.14.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Glenmark Pharmaceuticals (and Glenmark Generics)
2.15.1 Glenmark Pharmaceuticals (and Glenmark Generics) Details
2.15.2 Glenmark Pharmaceuticals (and Glenmark Generics) Major Business
2.15.3 Glenmark Pharmaceuticals (and Glenmark Generics) Product and Services
2.15.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ranitidine (Zantac) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ranitidine (Zantac) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ranitidine (Zantac) Manufacturer Market Share in 2019
3.3.2 Top 6 Ranitidine (Zantac) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ranitidine (Zantac) Sales, Revenue and Market Share by Regions
4.1.1 Global Ranitidine (Zantac) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ranitidine (Zantac) Revenue and Market Share by Regions (2015-2020)
4.2 North America Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
4.3 Europe Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
4.5 South America Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ranitidine (Zantac) Sales, Revenue and Market Share by Country
5.1.1 North America Ranitidine (Zantac) Sales and Market Share by Country (2015-2020)
5.1.2 North America Ranitidine (Zantac) Revenue and Market Share by Country (2015-2020)
5.2 United States Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
5.3 Canada Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
5.4 Mexico Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ranitidine (Zantac) Sales, Revenue and Market Share by Country
6.1.1 Europe Ranitidine (Zantac) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ranitidine (Zantac) Revenue and Market Share by Country (2015-2020)
6.2 Germany Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
6.3 UK Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
6.4 France Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
6.5 Russia Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
6.6 Italy Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ranitidine (Zantac) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ranitidine (Zantac) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ranitidine (Zantac) Revenue and Market Share by Regions (2015-2020)
7.2 China Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7.3 Japan Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7.4 Korea Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7.5 India Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
7.7 Australia Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ranitidine (Zantac) Sales, Revenue and Market Share by Country
8.1.1 South America Ranitidine (Zantac) Sales and Market Share by Country (2015-2020)
8.1.2 South America Ranitidine (Zantac) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
8.3 Argentina Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ranitidine (Zantac) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ranitidine (Zantac) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ranitidine (Zantac) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
9.3 Turkey Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
9.4 Egypt Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
9.5 South Africa Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ranitidine (Zantac) Sales and Market Share by Type (2015-2020)
10.2 Global Ranitidine (Zantac) Revenue and Market Share by Type (2015-2020)
10.3 Global Ranitidine (Zantac) Price by Type (2015-2020)
11 Global Ranitidine (Zantac) Market Segment by Application
11.1 Global Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
11.2 Global Ranitidine (Zantac) Revenue Market Share by Application (2015-2020)
11.3 Global Ranitidine (Zantac) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ranitidine (Zantac) Sales, Revenue and Growth Rate (2021-2025)
12.2 Ranitidine (Zantac) Market Forecast by Regions (2021-2025)
12.2.1 North America Ranitidine (Zantac) Market Forecast (2021-2025)
12.2.2 Europe Ranitidine (Zantac) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ranitidine (Zantac) Market Forecast (2021-2025)
12.2.4 South America Ranitidine (Zantac) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ranitidine (Zantac) Market Forecast (2021-2025)
12.3 Ranitidine (Zantac) Market Forecast by Type (2021-2025)
12.3.1 Global Ranitidine (Zantac) Sales Forecast by Type (2021-2025)
12.3.2 Global Ranitidine (Zantac) Market Share Forecast by Type (2021-2025)
12.4 Ranitidine (Zantac) Market Forecast by Application (2021-2025)
12.4.1 Global Ranitidine (Zantac) Sales Forecast by Application (2021-2025)
12.4.2 Global Ranitidine (Zantac) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Ranitidine (Zantac) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ranitidine (Zantac) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ranitidine (Zantac) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Ranitidine (Zantac) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Aventis Ranitidine (Zantac) Major Business
Table 10. Sanofi-Aventis Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi-Aventis SWOT Analysis
Table 12. Sanofi-Aventis Ranitidine (Zantac) Product and Services
Table 13. Sanofi-Aventis Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Strides (and Strides Arcolab international) Basic Information, Manufacturing Base and Competitors
Table 15. Strides (and Strides Arcolab international) Ranitidine (Zantac) Major Business
Table 16. Strides (and Strides Arcolab international) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 17. Strides (and Strides Arcolab international) SWOT Analysis
Table 18. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product and Services
Table 19. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Sun Pharma Ranitidine (Zantac) Major Business
Table 22. Sun Pharma Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 23. Sun Pharma SWOT Analysis
Table 24. Sun Pharma Ranitidine (Zantac) Product and Services
Table 25. Sun Pharma Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 27. GlaxoSmithKline Ranitidine (Zantac) Major Business
Table 28. GlaxoSmithKline Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 29. GlaxoSmithKline SWOT Analysis
Table 30. GlaxoSmithKline Ranitidine (Zantac) Product and Services
Table 31. GlaxoSmithKline Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Sandoz Inc. (part of Novartis AG) Basic Information, Manufacturing Base and Competitors
Table 33. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Major Business
Table 34. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 35. Sandoz Inc. (part of Novartis AG) SWOT Analysis
Table 36. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product and Services
Table 37. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Hi-Tech Pharmacal Co. Basic Information, Manufacturing Base and Competitors
Table 39. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Major Business
Table 40. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 41. Hi-Tech Pharmacal Co. SWOT Analysis
Table 42. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product and Services
Table 43. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. PAI Holdings, LLC Basic Information, Manufacturing Base and Competitors
Table 45. PAI Holdings, LLC Ranitidine (Zantac) Major Business
Table 46. PAI Holdings, LLC Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 47. PAI Holdings, LLC SWOT Analysis
Table 48. PAI Holdings, LLC Ranitidine (Zantac) Product and Services
Table 49. PAI Holdings, LLC Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Dr. Reddy’s Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 51. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Major Business
Table 52. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 53. Dr. Reddy’s Laboratories Inc. SWOT Analysis
Table 54. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product and Services
Table 55. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Basic Information, Manufacturing Base and Competitors
Table 57. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Major Business
Table 58. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 59. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) SWOT Analysis
Table 60. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product and Services
Table 61. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Geri-Care Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 63. Geri-Care Pharmaceuticals Ranitidine (Zantac) Major Business
Table 64. Geri-Care Pharmaceuticals Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 65. Geri-Care Pharmaceuticals SWOT Analysis
Table 66. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product and Services
Table 67. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 69. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Major Business
Table 70. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 71. Hikma Pharmaceuticals (West-ward Pharmaceuticals) SWOT Analysis
Table 72. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product and Services
Table 73. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 75. Teva Pharmaceuticals Ranitidine (Zantac) Major Business
Table 76. Teva Pharmaceuticals Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 77. Teva Pharmaceuticals SWOT Analysis
Table 78. Teva Pharmaceuticals Ranitidine (Zantac) Product and Services
Table 79. Teva Pharmaceuticals Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Apotex Inc. (and Apotex Corporation) Basic Information, Manufacturing Base and Competitors
Table 81. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Major Business
Table 82. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 83. Apotex Inc. (and Apotex Corporation) SWOT Analysis
Table 84. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product and Services
Table 85. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Granules Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 87. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Major Business
Table 88. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 89. Granules Pharmaceuticals Inc. SWOT Analysis
Table 90. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product and Services
Table 91. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Glenmark Pharmaceuticals (and Glenmark Generics) Basic Information, Manufacturing Base and Competitors
Table 93. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Major Business
Table 94. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Total Revenue (USD Million) (2018-2019)
Table 95. Glenmark Pharmaceuticals (and Glenmark Generics) SWOT Analysis
Table 96. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product and Services
Table 97. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Global Ranitidine (Zantac) Sales by Manufacturer (2018-2019) (K Units)
Table 99. Global Ranitidine (Zantac) Revenue by Manufacturer (2018-2019) (USD Million)
Table 100. Global Ranitidine (Zantac) Sales by Regions (2015-2020) (K Units)
Table 101. Global Ranitidine (Zantac) Sales Market Share by Regions (2015-2020)
Table 102. Global Ranitidine (Zantac) Revenue by Regions (2015-2020) (USD Million)
Table 103. North America Ranitidine (Zantac) Sales by Countries (2015-2020) (K Units)
Table 104. North America Ranitidine (Zantac) Sales Market Share by Countries (2015-2020)
Table 105. North America Ranitidine (Zantac) Revenue by Countries (2015-2020) (USD Million)
Table 106. North America Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020)
Table 107. Europe Ranitidine (Zantac) Sales by Countries (2015-2020) (K Units)
Table 108. Europe Ranitidine (Zantac) Sales Market Share by Countries (2015-2020)
Table 109. Europe Ranitidine (Zantac) Revenue by Countries (2015-2020) (USD Million)
Table 110. Asia-Pacific Ranitidine (Zantac) Sales by Regions (2015-2020) (K Units)
Table 111. Asia-Pacific Ranitidine (Zantac) Sales Market Share by Regions (2015-2020)
Table 112. Asia-Pacific Ranitidine (Zantac) Revenue by Regions (2015-2020) (USD Million)
Table 113. South America Ranitidine (Zantac) Sales by Countries (2015-2020) (K Units)
Table 114. South America Ranitidine (Zantac) Sales Market Share by Countries (2015-2020)
Table 115. South America Ranitidine (Zantac) Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020)
Table 117. Middle East & Africa Ranitidine (Zantac) Sales by Countries (2015-2020) (K Units)
Table 118. Middle East & Africa Ranitidine (Zantac) Sales Market Share by Countries (2015-2020)
Table 119. Middle East & Africa Ranitidine (Zantac) Revenue by Countries (2015-2020) (USD Million)
Table 120. Middle East & Africa Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020)
Table 121. Global Ranitidine (Zantac) Sales by Type (2015-2020) (K Units)
Table 122. Global Ranitidine (Zantac) Sales Share by Type (2015-2020)
Table 123. Global Ranitidine (Zantac) Revenue by Type (2015-2020) (USD Million)
Table 124. Global Ranitidine (Zantac) Revenue Share by Type (2015-2020)
Table 125. Global Ranitidine (Zantac) Sales by Application (2015-2020) (K Units)
Table 126. Global Ranitidine (Zantac) Sales Share by Application (2015-2020)
Table 127. Global Ranitidine (Zantac) Sales Forecast by Regions (2021-2025) (K Units)
Table 128. Global Ranitidine (Zantac) Market Share Forecast by Regions (2021-2025)
Table 129. Global Ranitidine (Zantac) Sales Forecast by Type (2021-2025) (K Units)
Table 130. Global Ranitidine (Zantac) Market Share Forecast by Type (2021-2025)
Table 131. Global Ranitidine (Zantac) Sales Forecast by Application (2021-2025)
Table 132. Global Ranitidine (Zantac) Market Share Forecast by Application (2021-2025)
Table 133. Direct Channel Pros & Cons
Table 134. Indirect Channel Pros & Cons
Table 135. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ranitidine (Zantac) Picture
Figure 2. Global Sales Market Share of Ranitidine (Zantac) by Type in 2019
Figure 3. Ranitidine Capsule Picture
Figure 4. Ranitidine Oral Tablet Picture
Figure 5. Ranitidine Injectable Solution Picture
Figure 6. Ranitidine Oral Syrup Picture
Figure 7. Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Online Pharmacy Picture
Figure 11. Global Ranitidine (Zantac) Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Ranitidine (Zantac) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Ranitidine (Zantac) Sales Market Share by Manufacturer in 2019
Figure 32. Global Ranitidine (Zantac) Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Ranitidine (Zantac) Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Ranitidine (Zantac) Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Ranitidine (Zantac) Revenue Market Share by Regions (2015-2020)
Figure 39. Global Ranitidine (Zantac) Revenue Market Share by Regions in 2018
Figure 40. North America Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
Figure 41. Europe Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
Figure 43. South America Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Ranitidine (Zantac) Sales and Growth Rate (2015-2020)
Figure 45. North America Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Ranitidine (Zantac) Sales Market Share by Countries (2015-2020)
Figure 47. North America Ranitidine (Zantac) Sales Market Share by Countries in 2018
Figure 48. North America Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Ranitidine (Zantac) Revenue Market Share by Countries in 2018
Figure 50. United States Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Ranitidine (Zantac) Revenue Market Share by Countries in 2019
Figure 56. Germany Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Ranitidine (Zantac) Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Ranitidine (Zantac) Revenue Market Share by Regions 2019
Figure 64. China Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Ranitidine (Zantac) Sales Market Share by Countries in 2019
Figure 71. South America Ranitidine (Zantac) Revenue Market Share by Countries in 2019
Figure 72. Brazil Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Ranitidine (Zantac) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Ranitidine (Zantac) Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Ranitidine (Zantac) Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Ranitidine (Zantac) Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Ranitidine (Zantac) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Ranitidine (Zantac) Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Ranitidine (Zantac) Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Ranitidine (Zantac) Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Ranitidine (Zantac) Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Ranitidine (Zantac) Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel